These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11495577)

  • 1. The first potent and selective inhibitors of the glycine transporter type 2.
    Caulfield WL; Collie IT; Dickins RS; Epemolu O; McGuire R; Hill DR; McVey G; Morphy JR; Rankovic Z; Sundaram H
    J Med Chem; 2001 Aug; 44(17):2679-82. PubMed ID: 11495577
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors.
    Ho KK; Appell KC; Baldwin JJ; Bohnstedt AC; Dong G; Guo T; Horlick R; Islam KR; Kultgen SG; Masterson CM; McDonald E; McMillan K; Morphy JR; Rankovic Z; Sundaram H; Webb M
    Bioorg Med Chem Lett; 2004 Jan; 14(2):545-8. PubMed ID: 14698200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and SAR of N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1.
    Cioffi CL; Wolf MA; Guzzo PR; Sadalapure K; Parthasarathy V; Dethe D; Maeng JH; Carulli E; Loong DT; Fang X; Hu M; Gupta P; Chung M; Bai M; Moore N; Luche M; Khmelnitsky Y; Love PL; Watson MA; Mhyre AJ; Liu S
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1257-61. PubMed ID: 23380375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5,5-Diaryl-2-amino-4-pentenoates as novel, potent, and selective glycine transporter type-2 reuptake inhibitors.
    Isaac M; Slassi A; Silva KD; Arora J; MacLean N; Hung B; McCallum K
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1371-3. PubMed ID: 11378357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and SAR of org 24598-a selective glycine uptake inhibitor.
    Brown A; Carlyle I; Clark J; Hamilton W; Gibson S; McGarry G; McEachen S; Rae D; Thorn S; Walker G
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2007-9. PubMed ID: 11454468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1.
    Cioffi CL; Liu S; Wolf MA; Guzzo PR; Sadalapure K; Parthasarathy V; Loong DT; Maeng JH; Carulli E; Fang X; Karunakaran K; Matta L; Choo SH; Panduga S; Buckle RN; Davis RN; Sakwa SA; Gupta P; Sargent BJ; Moore NA; Luche MM; Carr GJ; Khmelnitsky YL; Ismail J; Chung M; Bai M; Leong WY; Sachdev N; Swaminathan S; Mhyre AJ
    J Med Chem; 2016 Sep; 59(18):8473-94. PubMed ID: 27559615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides.
    Zhao Z; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Wolkenberg SE; Lindsley CW
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5968-72. PubMed ID: 16987662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of potent glycine transporter type-2 inhibitors: design and synthesis of phenoxymethylbenzamide derivatives.
    Takahashi E; Arai T; Akahira M; Nakajima M; Nishimura K; Omori Y; Kumagai H; Suzuki T; Hayashi R
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4603-4606. PubMed ID: 25176190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane glycine transport proteins.
    Tunnicliff G
    J Biomed Sci; 2003; 10(1):30-6. PubMed ID: 12566983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors.
    Zhao Z; Leister WH; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Lindsley CW; Wolkenberg SE
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1488-91. PubMed ID: 19179073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and expression of a glycine transporter from mouse brain.
    Liu QR; Nelson H; Mandiyan S; López-Corcuera B; Nelson N
    FEBS Lett; 1992 Jun; 305(2):110-4. PubMed ID: 1618338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor.
    Jursky F; Nelson N
    J Neurochem; 1995 Mar; 64(3):1026-33. PubMed ID: 7861131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel glycine transporter type-2 reuptake inhibitors. Part 1: alpha-amino acid derivatives.
    Wolin RL; Venkatesan H; Tang L; Santillán A; Barclay T; Wilson S; Lee DH; Lovenberg TW
    Bioorg Med Chem; 2004 Aug; 12(16):4477-92. PubMed ID: 15265498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diaminoindanes as microsomal triglyceride transfer protein inhibitors.
    Ksander GM; deJesus R; Yuan A; Fink C; Moskal M; Carlson E; Kukkola P; Bilci N; Wallace E; Neubert A; Feldman D; Mogelesky T; Poirier K; Jeune M; Steele R; Wasvery J; Stephan Z; Cahill E; Webb R; Navarrete A; Lee W; Gibson J; Alexander N; Sharif H; Hospattankar A
    J Med Chem; 2001 Dec; 44(26):4677-87. PubMed ID: 11741485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group-selective reagent modification of the sodium- and chloride-coupled glycine transporter under native and reconstituted conditions.
    Alcántara R; López-Corcuera B; Aragón C
    Biochim Biophys Acta; 1991 Aug; 1067(1):64-70. PubMed ID: 1651114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assignment of SLC6A9 to human chromosome band 1p33 by in situ hybridization.
    Jones EM; Fernald A; Bell GI; Le Beau MM
    Cytogenet Cell Genet; 1995; 71(3):211. PubMed ID: 7587377
    [No Abstract]   [Full Text] [Related]  

  • 19. Design, synthesis, and in vivo efficacy of glycine transporter-1 (GlyT1) inhibitors derived from a series of [4-phenyl-1-(propylsulfonyl)piperidin-4-yl]methyl benzamides.
    Lindsley CW; Zhao Z; Leister WH; O'Brien J; Lemaire W; Williams DL; Chen TB; Chang RS; Burno M; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Tsou NN; Duggan ME; Conn PJ; Hartman GD
    ChemMedChem; 2006 Aug; 1(8):807-11. PubMed ID: 16902933
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of a recombinant glycine transporter (GLYT1b) by activation of protein kinase C.
    Sato K; Adams R; Betz H; Schloss P
    J Neurochem; 1995 Nov; 65(5):1967-73. PubMed ID: 7595479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.